ACHE and Alzheimer disease: Thus, considering that AChE is one of the principal targets in AD and there are some benzothiazole tested as AChE inhibitors [39], in this work we have evaluated a set of benzothiazole-isothiourea derivatives as AChE inhibitors due to their pharmacological advantages.